Literature DB >> 20166137

ELL is an HIF-1alpha partner that regulates and responds to hypoxia response in PC3 cells.

Lingqi Liu1, Junkui Ai, Wuhan Xiao, June Liu, Yujuan Wang, Dianqi Xin, Zhisong He, Yinglu Guo, Zhou Wang.   

Abstract

BACKGROUND: Eleven-nineteen lysine-rich leukemia (ELL) plays an important role in tumorigenesis and animal development. HIF-1 is a transcriptional factor that functions as a master regulator of O(2) homeostasis. Our previous studies showed that a binding partner of ELL, U19/Eaf2, can modulate HIF-1alpha activity and hypoxia response, suggesting that ELL may also influence HIF-1alpha pathway and hypoxia response.
METHODS: Co-localization and co-immunoprecipitation were performed to test the interaction between ELL and HIF-1alpha. PC3 cells with stable ELL knockdown and PC3 cells with stable ELL overexpression, along with their controls, were established using lentiviral expression system. Western blot and real-time PCR were performed to test the effect of ELL on HIF-1alpha protein and its down-stream gene transcription. To elucidate potential effect of hypoxia on ELL, cell growth and colony formation assays were performed using PC3 subline with stable ELL overexpression.
RESULTS: ELL is associated with HIF-1alpha in transfected cells. In PC3 prostate cancer cells, ELL inhibited HIF-1alpha protein level and down-stream gene expression. As expected, ELL inhibited cell growth and colony formation under normoxia. Interestingly, the inhibition was alleviated under hypoxia.
CONCLUSIONS: Our findings suggest that ELL and HIF-1alpha are binding partners and can modulate the functions of each other in hypoxia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20166137      PMCID: PMC2857586          DOI: 10.1002/pros.21113

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  33 in total

1.  Functional analysis of the leukemia protein ELL: evidence for a role in the regulation of cell growth and survival.

Authors:  R W Johnstone; M Gerber; T Landewe; A Tollefson; W S Wold; A Shilatifard
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 2.  Angiogenesis: the role of the microenvironment in flipping the switch.

Authors:  F J Giordano; R S Johnson
Journal:  Curr Opin Genet Dev       Date:  2001-02       Impact factor: 5.578

3.  Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation.

Authors:  Joo Won Jeong; Moon Kyoung Bae; Mee Young Ahn; Se Hee Kim; Tae Kwon Sohn; Myung Ho Bae; Mi Ae Yoo; Eun Joo Song; Kong Joo Lee; Kyu Won Kim
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

4.  EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein.

Authors:  F Simone; P E Polak; J J Kaberlein; R T Luo; D A Levitan; M J Thirman
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

5.  Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.

Authors:  K Salnikow; M Costa; W D Figg; M V Blagosklonny
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

6.  Nonredundant roles of the elongation factor MEN in postimplantation development.

Authors:  K Mitani; T Yamagata; C Iida; H Oda; K Maki; M Ichikawa; T Asai; H Honda; M Kurokawa; H Hirai
Journal:  Biochem Biophys Res Commun       Date:  2000-12-20       Impact factor: 3.575

Review 7.  HIF-1 and tumor progression: pathophysiology and therapeutics.

Authors:  Gregg L Semenza
Journal:  Trends Mol Med       Date:  2002       Impact factor: 11.951

Review 8.  Role of angiogenesis in tumor growth and metastasis.

Authors:  Judah Folkman
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

9.  U19/Eaf2 binds to and stabilizes von hippel-lindau protein.

Authors:  Wuhan Xiao; Junkui Ai; Geoffrey Habermacher; Olga Volpert; Ximing Yang; Ai-Yuan Zhang; Junghyun Hahn; Xiaoyan Cai; Zhou Wang
Journal:  Cancer Res       Date:  2009-03-03       Impact factor: 12.701

10.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

View more
  7 in total

1.  Regulation of fertility, survival, and cuticle collagen function by the Caenorhabditis elegans eaf-1 and ell-1 genes.

Authors:  Liquan Cai; Binh L Phong; Alfred L Fisher; Zhou Wang
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

2.  Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.

Authors:  Laura E Pascal; Khalid Z Masoodi; June Liu; Xiaonan Qiu; Qiong Song; Yujuan Wang; Yachen Zang; Tiejun Yang; Yao Wang; Lora H Rigatti; Uma Chandran; Leandro M Colli; Ricardo Z N Vencio; Yi Lu; Jian Zhang; Zhou Wang
Journal:  J Endocrinol       Date:  2017-11       Impact factor: 4.286

3.  MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3.

Authors:  Lingqi Liu; Shuchao Liu; Qixin Duan; Liang Chen; Tianpeng Wu; Huijun Qian; Sixing Yang; Dianqi Xin; Zhisong He; Yinglu Guo
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

4.  MicroRNA-30a-3p functions as a tumor suppressor in renal cell carcinoma by targeting WNT2.

Authors:  Lingqi Liu; Liang Chen; Tianpeng Wu; Huijun Qian; Sixing Yang
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

5.  ELL inhibits E2F1 transcriptional activity by enhancing E2F1 deacetylation via recruitment of histone deacetylase 1.

Authors:  Wei Zhang; Wei Ji; Xing Liu; Gang Ouyang; Wuhan Xiao
Journal:  Mol Cell Biol       Date:  2013-12-16       Impact factor: 4.272

6.  Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy.

Authors:  Sami Heikkinen; Sami Väisänen; Petri Pehkonen; Sabine Seuter; Vladimir Benes; Carsten Carlberg
Journal:  Nucleic Acids Res       Date:  2011-08-16       Impact factor: 16.971

7.  ELL targets c-Myc for proteasomal degradation and suppresses tumour growth.

Authors:  Yu Chen; Chi Zhou; Wei Ji; Zhichao Mei; Bo Hu; Wei Zhang; Dawei Zhang; Jing Wang; Xing Liu; Gang Ouyang; Jiangang Zhou; Wuhan Xiao
Journal:  Nat Commun       Date:  2016-03-24       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.